| Trial ID: | L0020 |
| Source ID: | NCT00760513
|
| Associated Drug: |
OMACOR
|
| Title: |
Treatment of Non Alcoholic Fatty Liver Disease With n-3 Fatty Acids
|
| Acronym: |
WELCOME
|
| Status: |
Completed
|
| Study Results: |
Has Results
|
| Results: |
https://ClinicalTrials.gov/show/NCT00760513/results
|
| Conditions: |
Non-Alcoholic Fatty Liver Disease
|
| Interventions: |
Drug: OMACOR|Drug: Placebo oral capsule
|
| Outcome Measures: |
Percentage of Liver Fat|Liver Fibrosis Score|NAFLD Fibrosis Score
|
| Sponsor/Collaborators: |
University Hospital Southampton NHS Foundation Trust|National Institute for Health Research, United Kingdom
|
| Gender: |
All
|
| Age: |
18 Years to 75 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 4
|
| Enrollment: |
103
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment
|
| Start Date: |
November 1, 2009
|
| Completion Date: |
November 29, 2018
|
| Results First Posted: |
October 25, 2019
|
| Last Update Posted: |
October 25, 2019
|
| Locations: |
Southamption General Hospital, Southampton, Hants, United Kingdom
|
| URL: |
https://ClinicalTrials.gov/show/NCT00760513
|
